A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients
University of Arkansas
University of Arkansas
National Institutes of Health Clinical Center (CC)
Zealand University Hospital
Halozyme Therapeutics
Egetis Therapeutics
Academic Emergency County Hospital Sibiu
Woman's Health University Hospital, Egypt
Merck KGaA, Darmstadt, Germany
Columbia University
Arya, Vijaypal, M.D., P.C.
BioRegen Biomedical (CHangzhou) Co., Ltd
M.D. Anderson Cancer Center
Xiangya Hospital of Central South University
Hadassah Medical Organization